Vital Signs - Lucrative Therapeutic Markets: Opportunities, Challenges and Future Outlook

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on March 31, 2008, provides an strategic overview of selected lucrative market areas in the pharmaceutical industry. Additionally, a company spotlight is provided for Arena Pharmaceuticals, a clinical stage biopharmaceutical company focusing on developing innovative oral drugs for patients with serious diseases and disorders. Reimbursement and regulatory news from the FDA is also provided for the week of March 17 - March 21, 2008.

Table of Contents

Vital Signs - Lucrative Therapeutic Markets: Opportunities, Challenges and Future OutlookVital Signs: 31 March 2008This week's issue:




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.